Dr. Barlaskar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Moderna Tx, Inc.
200 Technology Square
Cambridge, MA 02139Phone+1 617-218-7770
Education & Training
- Yale-New Haven Medical CenterFellowship, Hematology and Medical Oncology, 2015 - 2018
- University of RochesterResidency, Internal Medicine, 2012 - 2015
- University of Michigan Medical SchoolClass of 2012
Certifications & Licensure
- IL State Medical License 2018 - 2026
- OH State Medical License 2024 - 2026
- ME State Medical License 2022 - 2024
- VA State Medical License 2021 - 2024
- WI State Medical License 2020 - 2023
- CT State Medical License 2015 - 2020
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 122 citationsPeroxisome Senescence in Human FibroblastsJulie E. Legakis, Jay I. Koepke, Christopher Jedeszko, Ferdous Barlaskar, Laura J. Terlecky
Molecular Biology of the Cell. 2002-12-01 - 132 citationsProgression to Adrenocortical Tumorigenesis in Mice and Humans through Insulin-Like Growth Factor 2 and β-CateninJoanne H. Heaton, Michelle A. Wood, Alex C. Kim, Lorena de Oliveira Lima, Ferdous M. Barlaskar
The American Journal of Pathology. 2012-09-01 - 20 citationsTrastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a...Eric Van Cutsem, Maria di Bartolomeo, Elizabeth Smyth, Ian Chau, Haeseong Park
The Lancet. Oncology. 2023-07-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: